PIMJS
RVMD icon

PKO Investment Management Joint-Stock’s Revolution Medicines RVMD Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$412K Buy
2,200
+700
+47% +$102K 0.03% 206
2026
Q1 		$146K Buy
+1,500
New +$151K 0.01% 216

Other funds holding RVMD

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

PKO Investment Management Joint-Stock's RVMD Position: Q2 2026 in Review

PKO Investment Management Joint-Stock increased its Revolution Medicines (RVMD) stake by 47% in Q2 2026, buying an estimated $102K and bringing the position to 2,200 shares worth $412K. The position accounts for 0.03% of the portfolio, ranked #206.

PKO Investment Management Joint-Stock first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 241 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • PKO Investment Management Joint-Stock held 2,200 shares of Revolution Medicines worth $412K as of Q2 2026.
  • PKO Investment Management Joint-Stock bought 700 Revolution Medicines shares in Q2 2026, an estimated $102K.
  • Revolution Medicines made up 0.03% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #206 holding.
  • PKO Investment Management Joint-Stock first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 241 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.